From Barron's 7-9-07: "Investor Robert L. Chapman Jr. reiterated his demand that American Community double its 10 cents-a-share quarterly dividend. Chapman may consider various means to maximize shareholder value, including negotiated transactions, tender offers, proxy contests or other actions. Chapman currently holds 395,302 shares (7.6% of the total outstanding)."

From Barron's 7-9-07: "Triarc Cos. (TRY) has notified Wendy's that it considers itself "a natural, strategic buyer" of the hamburger chain, but contends that Wendy's is seeking to block any transaction. Triarc says it had been invited to participate in Wendy's potential sale process, but that the confidentiality agreement it received from an investment banker has a "restrictive one-year standstill clause to which Triarc has objected." Triarc's non-executive chairman, billionaire Nelson Peltz, holds 8.55 million Wendy's shares (9.8%). He'd been Triarc's CEO until resigning that post last week."

From Barron's 7-9-07: "SCO Capital Partners said that Genzyme's (GENZ) "failed" tender offer for Bioenvision proves that the $5.60-a-share bid was too low. SCO Capital says that the offer is well below UBS Securities' price target of $13. Genzyme is extending the offer until July 10 and waiving a condition that it acquire at least 50% of Bioenvision's outstanding common. SCO Capital Partners has 7,209,331 shares (13.4%)."

From Barron's 7-9-07: "Pirate Capital wants Angelica to take "immediate steps" to unlock shareholder value by retaining an investment bank to explore strategic alternatives, including a possible sale. Pirate Capital otherwise may nominate directors at the annual meeting. Pirate also wants to examine and copy some of the company's books, records and documents. Pirate Capital owns 935,147 shares (9.8%)."

From Barron's 7-9-07: "Admiral Advisors says the company's stock is significantly undervalued and wants Kensey Nash to focus on its core biomaterials business. Admiral Advisors believes that Kensey Nash could save up to $20 million a year by ending direct sales and significantly curbing research and development expenses for its endovascular line. The shareholder wants the board to consider a Dutch-auction tender offer to repurchase stock. Admiral Advisors owns 1,180,634 shares (9.9%)."

From Barron's 7-9-07: "Dorset Management has asked Magna to add an independent director to its board. Dorset owns 3,394,014 shares (6.9%)."

From Barron's 7-9-07: "Thesis Capital Management raised its holdings to 696,692 shares (8.6%) from the 611,799 (7.6%) reported in late May."

From Barron's 7-9-07: "Van Den Berg Management boosted its stake to 11.6 million shares (24. 4%) from the 10.7 million (22.51%) reported on June 28."